Submitted:
08 May 2023
Posted:
09 May 2023
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Model Description
| Symbols | Definitionss |
| Number of susceptible humans at time t and discrete age | |
| Number of exposed humans at time t and discrete age | |
| Number of infectious humans at time t and discrete age | |
| Number of recovered humans at time t and discrete age | |
| Number of susceptible black-flies at time t | |
| Number of exposed black-flies at time t | |
| Number of infectious black-flies at time t | |
| Recruitment term of the susceptible humans at discrete age | |
| Recruitment term of the susceptible vectors | |
| Biting rate of the vector | |
| Probability that a bite by an infectious vector results in transmission of disease to human at discrete age | |
| Probability that a bite results in transmission of parasite to a susceptible vector | |
| Per capita death rate of humans at discrete age | |
| Per capita death rate of vector | |
| Disease-induced death rate of humans at discrete age | |
| Disease-induced death rate of vectors | |
| Per capita rate of progression of humans from the exposed state to the infectious state at discrete age | |
| Per capita rate of progression of vectors from the exposed state to the infectious state | |
| Per capita recovery rate for humans from the infectious state to the recovered state due to treatment at discrete age | |
| Per capita transition rate of recovered humans to the susceptible state at discrete age | |
| Humans disease-inhibiting factor at discrete age | |
| Vectors disease-inhibiting factor |
- 1.
- That all humans are born susceptible. That is, humans are liable to contract the disease.
- 2.
- That the susceptible humans, when infected, becomes exposed humans who are not yet infectious.
- 3.
- That the exposed humans progress to become infectious only.
- 4.
- That the infectious humans may either die naturally or as a result of the disease, and if not, they become recovered humans due to treatment.
- 5.
- That the recovered humans become susceptible again.
- 6.
- All black-flies are born susceptible.
- 7.
- That the susceptible black-flies, when infected, becomes exposed black-flies who are not yet infectious.
- 8.
- That the exposed black-flies progress to become infectious only.
- 9.
- That the infectious black-flies remain infectious for life. That is, there is no recovered class for black-fly population.
2.1. Existence and Positivity of Solutions
3. Existence and stability of the equilibrium points
3.1. Disease-free equilibrium
3.2. Local Stability of the Disease-free Equilibrium Point
3.3. Endemic Equilibrium Point
4. Bifurcation Analysis
- 1.
- is the linearization matrix of the system (4.1) around the equilibrium 0 with evaluated at 0. Zero is a simple eigenvalue of A and other eigenvalues of A have negative real parts;
- 2.
- Matrix A has a nonnegative right eigenvector and a left eigenvector corresponding to the zero eigenvalue.
- (i)
- , . When with , 0 is locally asymptotically stable and there exists a positive unstable equilibrium; when , 0 is unstable and there exists a negative, locally asymptotically stable equilibrium;
- (ii)
- , . When with , 0 is unstable; when 1, 0 is locally asymptotically stable, and there exists a positive unstable equilibrium;
- (iii)
- , . When with , 0 is unstable, and there exists a locally asymptotically stable negative equilibrium; when , 0 is stable, and a positive unstable equilibrium appears;
- (iv)
- , . When changes from negative to positive, 0 changes its stability from stable to unstable. Correspondingly a negative unstable equilibrium becomes positive and locally asymptotically stable. In particular, if and , then there exists a backward bifurcation.
References
- W. S. Alley, B.A.B. Boatin, N.J.D.N. Nagelkerke, Macrofilaricides and onchocerciasis control, mathematical modelling of the prospects for elimination. BMC Public Health 1(1) (2001), p. 12.
- U. Amazigo, M. Noma, J. Bump, B. Bentin, B. Liese, L. Yameogo, H. Zouré, and A. Seketeli, Onchocerciasis Disease and Mortality in Sub Saharan Africa, Chapter 15, World Bank, Washington, DC, 2006.
- Asha Hassan & Nyimvua Shaban (2020) Onchocerciasis dynamics: modelling the effects of treatment, education and vector control, Journal of Biological Dynamics, 14:1, 245-268. [CrossRef]
- Castillo-Chavez, C. and Song, B. 2004. Dynamical models of tuberculosis and their applications. Mathematical Biosciences and Engineering 1.2: 361-404.
- Eric M Poolman and Alison P Galvani. Modeling targeted ivermectin treatment for controlling river blindness. The American Journal of Tropical Medicine and Hygiene, 75(5):921–927, 2006.
- Jimmy P Mopecha and Horst R Thieme. Competitive Dynamics in a Model for Onchocerciasis with Cross-Immunity. Canadian Applied Mathematics Quarterly, 11(4):339–376, 2003.
- María-Gloria Basáñez and Michel Boussinesq. Population biology of human onchocerciasis. Philosophical Transactions of the Royal Society of London B: Biological Sciences, 354(1384):809–826, 1999.
- María-Gloria Basáñez and Jorge Ricárdez-Esquinca. Models for the population biology and control of human onchocerciasis. Trends in Parasitology, 17(9):430–438, 2001.
- Murray, J. D. 2002. Mathematical biology I., an introduction. 3rd ed. Heidelberg: Springer-Verlag Berlin.
- A.P. Plaisier, E.S. Alley, G.J. van Oortmarssen, B.A. Boatin, and J.D.F Habbema, Required duration of combined annual ivermectin treatment and vector control program in west africa, Bull. World Health Organ. 75(3) (1997), pp. 237.
- J. Remme, G. De Sole, and G.J. van Oortmarssen, The predicted and observed decline in onchocerciasis infection during 14 years of successful control of black flies in West Africa, Bull. World Health Organ.68(3) (1990), pp. 331–339.
- Shaib Ismail Omade, Adeyemi Tajudeen Omotunde, and Akinyemi Seye Gbenga. Mathematical Modeling of River Blindness Disease with Demography Using Euler Method. Mathematical Theory and Modeling, 5(5):75–85, 2015.
- World Health Organization, African programme for onchocerciasis control: Meeting of national onchocerciasis task forces, September 2012, Weekly Epidemiol. Record 87(49–50) (2012), pp. 494–502.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).